Master transcription factor reprograming unleashes selective translation promoting castration resistance and immune evasion in lethal prostate cancer

Related articles

eBlogs

04
28
24

RNA therapeutics: a review of the future of medicine | eBlog

RNA therapeutics have revolutionized medicine. In this eBlog we discuss the different types of RNA therapeutics that have received FDA approval.

read more

eBlogs

04
11
24

Discovering miRNA regulation with miR-eCLIP | eBlog

miRNAs are key regulators of expression and translation, however identifying where and how they bind can be a challenge. In this eBlog we reveal how miR-eCLIP can be used to directly profile miRNA activity...[READ MORE]

read more

eBlogs

02
26
24

Successful mRNA therapeutic design: optimizing for stability and translation | eBlog

mRNA therapeutics have unlocked the potential for rapid responses to infectious disease, personalized treatments for cancer, and protein replacement for different diseases. To ensure efficacy, specific features need to be included in the therapeutic to promote stability, efficient translation, and to... [READ MORE]

read more

eBlogs

01
30
24

How to find stalled ribosomes | eBlog

Monitoring translation dynamics at the gene level can be effectively achieved by employing ribosome profiling techniques, such as Eclipsebio’s eRibo Pro technology...[READ MORE]

read more